TNFRSF8 and lymphoma: The PRIME notation has potential for universal applicability to antibodies other than the anti-CD30 antibody used in this study, and multivariate analysis of FCM and immunohistochemistry big data in malignant lymphoma has the potential to show the relationship between genetic mutations and translocations, tumor malignancy, and prognosis.